|

Standard-dose rivaroxaban Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • China National Center for Cardiovascular Diseases1

Indications

  • Major Adverse Cardiac Events1
  • Anticoagulant Adverse Reaction1
  • Heart Disease1
  • Atrial Fibrillation1
  • Stroke1

Other1 trial

Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.